One Critical Mistake You Can Make in the Pursuit of Open Innovation

October 01, 2013
I recently attended TechScout 2013 in Amsterdam where I was able to listen to a variety of presentations on corporate open innovation programs. The event included participants who were in leadership roles as technology scouts and also showcased the resurgence of corporate venturing programs. Read More

The Number One Thing We Learned at Our First User Group Meeting

August 26, 2013
Everyone is getting back and settled in after the inaugural Wellspring Worldwide Sophia User Group meeting. I can’t speak for everyone who attended, I know all of us at Wellspring Worldwide had a great time and learned a lot, too. The User Group was a huge success, with more than 70 Sophia users... Read More

Snails and Solutions in the Nation’s Capital

August 14, 2013
What do competitive swimming, escargot, and stuffed owls have in common? Read More

The Optimal Level for Open Innovation Investment is 34%

August 06, 2013
A large number of papers, books, and blogs have touted the value and amount of investment devoted to Open Innovation. The focus has been the latest types of programs, case studies on particular companies, and “best” practices. However, a recent study has tried to measure the R&D performance from... Read More

Looking for a model Open Innovation Ecosystem… you’ll need to go to Mars.

July 22, 2013
Its not often you go to Mars. But I spent the last week there and, while its very very hot from a temperature standpoint, the technology and infrastructure are the more impressive aspects. Read More

IFT’s Food EXPO Comes to Chicago – With Salt Spheres and a Tip of the Cap

July 18, 2013
One might not think that Open Innovation and food have a whole lot in common, but I learned that’s not the case at all. The Institute of Food Technologists’ annual showpiece, the IFT Food EXPO, was recently held at Chicago’s McCormick Place Convention Center and I had a chance to stop by. With... Read More

Who Owns that Patent? 3 Ways to Avoid 30 Years of Disputes.

April 16, 2013
Pfizer and the NIH have taken sides on who owns background intellectual property (IP) rights to the blockbuster arthritis drug Xeljanz. Its undisputed that Pfizer invested over $1B in the drug, and its undisputed that Pfizer and NIH had an joint R&D contract, called a CRADA, in place during the... Read More

CoDev 2013... and Soap

February 12, 2013
We're at the CoDev conference in La Jolla, California. CoDev is co-organized by the PDMA and brings together an exciting array of companies committed to developing their products and services through active partnerships with outside organizations (Co-Development!, Open Innovation, JV's, etc.,). Read More
1 2 3 4 5

BROWSE CATEGORIES

SIGN UP
FOR EMAIL UPDATES

LEARN WHAT WELLSPRING CAN DO FOR YOU

Let's Talk